PT84219A - Process for the preparation of an antiviral compound containin g an antiviral purine nucleoside and a transport inhibiting nucleoside - Google Patents

Process for the preparation of an antiviral compound containin g an antiviral purine nucleoside and a transport inhibiting nucleoside

Info

Publication number
PT84219A
PT84219A PT84219A PT8421987A PT84219A PT 84219 A PT84219 A PT 84219A PT 84219 A PT84219 A PT 84219A PT 8421987 A PT8421987 A PT 8421987A PT 84219 A PT84219 A PT 84219A
Authority
PT
Portugal
Prior art keywords
nucleoside
antiviral
preparation
transport inhibiting
containin
Prior art date
Application number
PT84219A
Other languages
English (en)
Other versions
PT84219B (pt
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PT84219A publication Critical patent/PT84219A/pt
Publication of PT84219B publication Critical patent/PT84219B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PT84219A 1986-01-30 1987-01-29 Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor PT84219B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868602346A GB8602346D0 (en) 1986-01-30 1986-01-30 Antiviral combinations

Publications (2)

Publication Number Publication Date
PT84219A true PT84219A (en) 1987-02-01
PT84219B PT84219B (pt) 1989-07-31

Family

ID=10592262

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84219A PT84219B (pt) 1986-01-30 1987-01-29 Processo para a preparacao de uma composicao antiviral contendo um nucleosido de purina antiviral e um nucleosido de transporte inibidor

Country Status (20)

Country Link
US (1) US4897394A (pt)
EP (1) EP0235931B1 (pt)
JP (1) JPS62195337A (pt)
KR (1) KR870006900A (pt)
AT (1) ATE54414T1 (pt)
AU (1) AU590817B2 (pt)
CA (1) CA1283361C (pt)
DD (1) DD261095A5 (pt)
DE (1) DE3763597D1 (pt)
DK (1) DK46787A (pt)
ES (1) ES2031883T3 (pt)
FI (1) FI870377A (pt)
GB (1) GB8602346D0 (pt)
GR (1) GR3000638T3 (pt)
HU (1) HU198394B (pt)
IL (1) IL81422A0 (pt)
MC (1) MC1791A1 (pt)
PL (1) PL263871A1 (pt)
PT (1) PT84219B (pt)
ZA (1) ZA87667B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
WO1994018979A2 (en) * 1993-02-19 1994-09-01 Southern Research Institute Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs
AU6516494A (en) * 1993-04-15 1994-11-08 New York University Adenosine receptor agonists for the promotion of wound healing
EP0746319A4 (en) * 1993-05-12 1997-11-05 Karl Y Hostetler ACYCLOVIR DERIVATIVES FOR TOPICAL USE
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5677308A (en) * 1996-12-19 1997-10-14 Lerner; A. Martin Method for alleviating spasmodic torticollis
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en) * 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
JP2005519868A (ja) * 2001-10-16 2005-07-07 アバニール・ファーマシューティカルズ n−ドコサノールによるウイルス阻害
WO2013023362A1 (zh) * 2011-08-16 2013-02-21 深圳市卫武光明生物制品有限公司 静注巨细胞病毒人免疫球蛋白及其制备方法
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
CN105079404A (zh) * 2015-09-07 2015-11-25 夏云强 一种治疗多重耐药菌所致感染性创面的中药外洗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
ATE33653T1 (de) * 1982-10-14 1988-05-15 Wellcome Found Antivirale purinderivate.
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
EP0206497B1 (en) * 1985-05-15 1994-07-20 The Wellcome Foundation Limited Therapeutic nucleosides and their preparation
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
KR870006900A (ko) 1987-08-13
DE3763597D1 (de) 1990-08-16
HUT42941A (en) 1987-09-28
FI870377A (fi) 1987-07-31
GB8602346D0 (en) 1986-03-05
MC1791A1 (fr) 1987-10-22
PL263871A1 (en) 1988-05-12
DD261095A5 (de) 1988-10-19
GR3000638T3 (en) 1991-09-27
ES2031883T3 (es) 1993-01-01
CA1283361C (en) 1991-04-23
HU198394B (en) 1989-10-30
PT84219B (pt) 1989-07-31
EP0235931B1 (en) 1990-07-11
ATE54414T1 (de) 1990-07-15
AU590817B2 (en) 1989-11-16
AU6813587A (en) 1987-08-06
US4897394A (en) 1990-01-30
IL81422A0 (en) 1987-08-31
FI870377A0 (fi) 1987-01-29
DK46787A (da) 1987-07-31
DK46787D0 (da) 1987-01-29
ZA87667B (en) 1988-09-28
JPS62195337A (ja) 1987-08-28
EP0235931A1 (en) 1987-09-09

Similar Documents

Publication Publication Date Title
PT84219A (en) Process for the preparation of an antiviral compound containin g an antiviral purine nucleoside and a transport inhibiting nucleoside
EP0135713A3 (en) Antiviral combinations
EP0375329A3 (en) Antiviral pyrimidine and purine compounds, process for their preparation and pharmaceutical compositions containing them
PT86356A (en) Process for the preparartion of nucleoside compounds of antiviral pyrimidine and pharmaceutical compositions therewith
MY121839A (en) Antiviral purine derivatives
IL104976A0 (en) Nucleoside analogues,their preparation and pharmaceutical compositions containing them
NZ513849A (en) Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
EP0334361A3 (en) Novel acetylenic, cyano and allenic aristeromycin/adenosine derivatives
IE831386L (en) Pharmaceutical compositions based on xylosides and lyxosides¹of purine and pyrimidine bases
HUP0300219A2 (hu) L-nukleozidokat, L-nukleotidokat és analógjaikat tartalmazó készítmények és alkalmazásuk
ATE72122T1 (de) Antivirale mischungen.
IL93001A0 (en) Purine nucleosides and nucleotides,processes for the preparation thereof and pharmaceutical compositions containing the same
MX9709782A (es) Derivados de aciclovir para aplicacion topica.